Convergence Pharmaceuticals Limited
Records under this name other than the patents Convergence Pharmaceuticals Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Back to Convergence Pharmaceuticals Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,045,485 | Ask 1 Inhibiting Pyrrolopyrimidine Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 7,855,218 | Novel Compounds Term ended Ended no later than Nov 14, 2026 · Medium confidence | Term ended | Ended no later than Nov 14, 2026 | Medium confidence |
| US 10,010,551 | Novel Pyrimidinyl-Diazospiro Compounds Lapsed on the fee record Ended Jul 3, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 3, 2026 | Medium confidence |
| US 8,759,542 | Process for Preparing Alpha-Carboxamide Derivatives Lapsed on the fee record Ended Jun 24, 2026 · High confidence | Lapsed on the fee record | Ended Jun 24, 2026 | High confidence |
| US 9,737,536 | Novel Pyrimidinyl-DiazoSpiro Compounds Lapsed on the fee record Ended Aug 22, 2025 · Medium confidence | Lapsed on the fee record | Ended Aug 22, 2025 | Medium confidence |
| US 9,585,886 | Ask 1 Inhibiting Pyrrolopyrimidine Derivatives Formerly held Lapsed on the fee record Ended Mar 7, 2025 · Medium confidence | Lapsed on the fee record | Ended Mar 7, 2025 | Medium confidence |
| US 9,376,436 | 2-(pyridin-2yl)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulators Lapsed on the fee record Ended Jun 28, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 28, 2024 | From the USPTO record |
| US 9,376,445 | Novel Pyrimidinyl-Diazospiro Compounds Lapsed on the fee record Ended Jun 28, 2024 · Medium confidence | Lapsed on the fee record | Ended Jun 28, 2024 | Medium confidence |
| US 9,309,254 | Pyrimidinyl-diazospiro compounds Lapsed on the fee record Ended Apr 12, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 12, 2024 | From the USPTO record |
| US 8,153,623 | Novel Compounds Formerly held Lapsed on the fee record Ended Apr 10, 2024 · Medium confidence | Lapsed on the fee record | Ended Apr 10, 2024 | Medium confidence |